EU experts weigh up medical DEHP risks

Policymakers should consider the potential for replacing the phthalate DEHP in medical devices but must weigh up factors including its usefulness in treatment, experts told the European Commission

by Valerie Flynn

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here

Email: subs@endseurope.com

Call: 020 8267 8120

Register for
Free Trial

  • 30 days limited access to subscriber-only content
  • Free ENDS Europe Daily email bulletin

Register

Subscribe

Prices on request

  • Full access to endseurope.com for 12 months
  • Infringements Dashboard - Understand how current environmental directives are being interpreted and where the pitfalls are for member states
  • Individual and bespoke multi-user packages available

See all benefits